Does Insurance Cover GLP-1 for Weight Loss?

Insurance coverage for GLP-1 weight loss medications has been one of the biggest barriers to access. Here is the current landscape and how to navigate it.

The Coverage Challenge

Historically, most insurance plans excluded anti-obesity medications (AOMs) from coverage. A 2023 analysis by the Obesity Action Coalition found that:

• Only 25-30% of commercial insurance plans covered AOMs before 2024
• Medicare Part D was explicitly prohibited by law from covering weight loss drugs
• Medicaid coverage varied dramatically by state

However, the landscape is rapidly changing.

Private Insurance Coverage (2026)

Current State

Coverage has expanded significantly:

• A 2025 survey by the Kaiser Family Foundation found that approximately 50% of large employer plans now include at least one GLP-1 for weight management
• This is up from roughly 25% in 2023 and 40% in 2024
• The trend is accelerating as employers recognize the long-term health cost savings

What Plans Typically Require

Even when covered, most plans impose conditions:

1. Prior authorization - Your doctor must submit paperwork documenting medical necessity
2. BMI threshold - Usually BMI ≥30, or ≥27 with comorbidities
3. Step therapy - Some plans require trying other weight loss approaches first (diet counseling, other medications like phentermine)
4. Specialist referral - Some plans require a referral from a specialist
5. Copay/coinsurance - Even covered medications may have significant out-of-pocket costs ($50-$300/month)

Tips for Getting Coverage

• Review your formulary - Look up your specific plan's drug list
• Get documentation ready - BMI history, comorbidities, prior weight loss attempts
• Have your doctor be specific - Medical necessity letters citing clinical guidelines improve approval rates
• Use the correct diagnosis code - Obesity (E66.01) rather than just "overweight"

Medicare Coverage

What Changed

The Treat and Reduce Obesity Act provisions, phased in starting in 2025, expanded Medicare Part D coverage to include anti-obesity medications. This was a landmark change affecting over 60 million Medicare beneficiaries.

Current Medicare Coverage Details

• Medicare Part D plans can now cover GLP-1 medications prescribed for weight loss
• Individual Part D plans have discretion on which specific drugs to include
• Copays and prior authorization requirements vary by plan
• For patients with Type 2 diabetes, GLP-1 medications were already covered under Part D

What to Do

• Contact your Part D plan directly to ask about specific medication coverage
• Review the plan formulary (available on the plan's website or Medicare.gov)
• Consider switching Part D plans during open enrollment if your current plan does not cover the medication you need

Medicaid Coverage

Medicaid coverage varies significantly by state:

States with broader GLP-1 coverage for weight loss:

• Several states have added or expanded coverage in 2024-2025
• Check with your state Medicaid program for current status

Common Medicaid requirements:

• Prior authorization almost always required
• May require enrollment in a weight management program
• Formulary restrictions may limit which GLP-1 is covered

How to Appeal a Denial

If your insurance denies coverage, you have the right to appeal. Here is a step-by-step process:

Level 1: Internal Appeal

1. Request the denial in writing with the specific reason
2. Gather supporting documentation:
   • Detailed letter from your prescribing doctor
   • Your BMI history and weight-related conditions
   • Documentation of prior weight loss attempts
   • Relevant clinical guidelines (AMA, Endocrine Society)
   • Published clinical trial data
3. Submit the appeal within the timeframe specified (usually 60-180 days)
4. Include peer-reviewed evidence - The SELECT cardiovascular outcomes trial is particularly powerful for appeals

Level 2: External Review

If the internal appeal is denied:

• You can request an independent external review by a third party
• This is required by law for most insurance plans
• The external reviewer is not affiliated with your insurance company

Success Rates

According to a 2024 analysis by the Patient Advocate Foundation:

• Approximately 40-50% of first-level appeals for GLP-1 medications are successful
• External reviews have even higher success rates
• Appeals that include detailed medical documentation and clinical guidelines are most likely to succeed

Employer Advocacy

If your employer's plan does not cover GLP-1 medications:

• Speak to your HR department - Benefits are reviewed annually, and employee feedback matters
• Provide evidence - Share data on long-term cost savings (reduced diabetes, cardiovascular, and joint replacement costs)
• Join employee advocacy groups - Collective requests carry more weight
• Reference the clinical evidence - The SELECT trial showing 20% cardiovascular event reduction is a powerful argument for coverage

The Bottom Line

Insurance coverage for GLP-1 weight loss medications is improving rapidly but remains inconsistent. Check your specific plan, use manufacturer savings programs, and do not accept an initial denial as final - appeals are often successful. The trend is clearly toward broader coverage as the evidence base for GLP-1 medications continues to grow.

For cost-saving strategies, see our complete cost guide. And track your medication with GLP Pal to stay on schedule.